CY1111729T1 - Υπογλωσσιο επικαλυμμενο δισκιο - Google Patents

Υπογλωσσιο επικαλυμμενο δισκιο

Info

Publication number
CY1111729T1
CY1111729T1 CY20111100746T CY111100746T CY1111729T1 CY 1111729 T1 CY1111729 T1 CY 1111729T1 CY 20111100746 T CY20111100746 T CY 20111100746T CY 111100746 T CY111100746 T CY 111100746T CY 1111729 T1 CY1111729 T1 CY 1111729T1
Authority
CY
Cyprus
Prior art keywords
balanced
covered tablet
tablet
covered
fentanyl
Prior art date
Application number
CY20111100746T
Other languages
English (en)
Inventor
Pascal Oury
Guillaume Benoist
Catherine Herry
Joseph Duvochel
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm filed Critical Ethypharm
Publication of CY1111729T1 publication Critical patent/CY1111729T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Abstract

Η παρούσα εφεύρεση σχετίζεται με υπογλώσσιο επικαλυμμένο δισκίο και με τη μέθοδο παρασκευής αυτού. Το δισκίο περιλαμβάνει πυρήνα άνευ φαρμακευτικά δραστικής ουσίας, και επικάλυψη περιλαμβάνουσα τουλάχιστον μία δραστική ουσία. Η προτιμώμενη δραστική ουσία είναι οπιοειδές αναλγητικό.
CY20111100746T 2005-03-18 2011-08-03 Υπογλωσσιο επικαλυμμενο δισκιο CY1111729T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502727A FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe
EP06724230A EP1858491B1 (en) 2005-03-18 2006-03-20 Sublingual coated tablet

Publications (1)

Publication Number Publication Date
CY1111729T1 true CY1111729T1 (el) 2015-10-07

Family

ID=35309611

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100746T CY1111729T1 (el) 2005-03-18 2011-08-03 Υπογλωσσιο επικαλυμμενο δισκιο

Country Status (26)

Country Link
US (2) US8709479B2 (el)
EP (1) EP1858491B1 (el)
JP (1) JP5138577B2 (el)
KR (1) KR101239926B1 (el)
CN (1) CN101141951B (el)
AT (1) ATE507824T1 (el)
AU (1) AU2006224690B2 (el)
BR (1) BRPI0608505B8 (el)
CA (1) CA2599502C (el)
CY (1) CY1111729T1 (el)
DE (1) DE602006021713D1 (el)
DK (1) DK1858491T3 (el)
ES (1) ES2365984T3 (el)
FR (1) FR2883179B1 (el)
HK (1) HK1109730A1 (el)
IL (1) IL185626A (el)
MX (1) MX2007011440A (el)
NO (1) NO338771B1 (el)
NZ (1) NZ561154A (el)
PL (1) PL1858491T3 (el)
PT (1) PT1858491E (el)
RU (1) RU2403043C2 (el)
SI (1) SI1858491T1 (el)
UA (1) UA88509C2 (el)
WO (1) WO2006097361A1 (el)
ZA (1) ZA200707900B (el)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
CN106727271B (zh) * 2006-01-06 2020-02-14 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
DE102006054638B4 (de) * 2006-11-16 2014-12-04 Laburnum Gmbh Pharmazeutische Einzeldosisform
JP5503292B2 (ja) * 2007-01-05 2014-05-28 エーセルアールエックス ファーマシューティカルズ， インコーポレイテッド 経粘膜剤形の投与のための貯蔵および投与デバイス
WO2008100434A1 (en) * 2007-02-09 2008-08-21 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
DK2604257T3 (en) * 2007-08-07 2017-08-28 Acelrx Pharmaceuticals Inc ORAL TRANSMUCOSAL DOSAGE FORMS INCLUDING SUFENTANIL AND TRIAZOLAM
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
US20090263476A1 (en) * 2008-04-16 2009-10-22 Jobdevairakkam Christopher N Composition of Rapid Disintegrating Direct Compression Buccal Tablet
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2952191B1 (en) * 2009-06-12 2018-08-22 Sunovion Pharmaceuticals Inc. Sublingual apomorphine
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
US20110288128A1 (en) * 2010-05-21 2011-11-24 Acelrx Pharmaceuticals, Inc. Oral Transmucosal Administration of Sufentanil
EP2455069A1 (de) * 2010-11-11 2012-05-23 Laburnum GMBH Wirkstofffreie Darreichungsform, Verfahren zu deren Herstellung sowie deren Verwendung
BR112013015939A2 (pt) * 2010-12-23 2020-08-04 Purdue Pharma L.P. formas farmacêuticas orais sólidas resistentes à adulteração
BR112013029199B1 (pt) * 2011-05-13 2022-02-08 Eb Ip Hybritabs B.V. Dispositivo de distribuição de dois fármacos
DK2706986T3 (en) * 2011-09-19 2015-06-01 Orexo Ab NEW ADDICTION PREVENTING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OPIOID ADDICTION
CA2871805A1 (en) 2012-05-02 2013-11-07 Orexo Ab New alfentanil composition for the treatment of acute pain
CN102755322B (zh) * 2012-07-24 2013-12-11 兆科药业（广州）有限公司 一种乐卡地平和阿托伐他汀复方制剂
JP6539274B2 (ja) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 押出成形された即放性乱用抑止性丸剤
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP2886103A1 (en) * 2013-12-23 2015-06-24 Hexal AG Pharmaceutical orodispersible film comprising buprenorphine particles with a particular size
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
EP3578164A1 (en) 2018-06-05 2019-12-11 Bio-Gate AG Thixotropic composition
CN209673136U (zh) 2019-05-07 2019-11-22 深圳市华普森电子有限公司 高清智能一体化管道探测器

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL282752A (el) * 1961-09-10
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
FR2621483B1 (fr) 1987-10-08 1991-09-20 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
US5202128A (en) 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
AU5592694A (en) * 1992-11-05 1994-05-24 Merck & Co., Inc. Drug delivery device
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5744164A (en) 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2769524B1 (fr) * 1998-01-06 1999-12-31 Ethypharm Lab Prod Ethiques Dispositif d'enrobage pour granules a absorber par voie orale
FR2774910B1 (fr) 1998-02-16 2001-09-07 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20010016593A1 (en) * 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
FR2794646B1 (fr) 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
FR2796840B1 (fr) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6602518B2 (en) * 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
EP1414418A1 (en) 2001-08-06 2004-05-06 Euro-Celtique S.A. Compositions and methods to prevent abuse of opioids
US20030191147A1 (en) * 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
WO2004067004A1 (en) * 2003-01-31 2004-08-12 Orexo Ab A rapid-acting pharmaceutical composition
FR2855756B1 (fr) 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe

Also Published As

Publication number Publication date
RU2007138647A (ru) 2009-04-27
PT1858491E (pt) 2011-08-18
KR101239926B1 (ko) 2013-03-07
EP1858491B1 (en) 2011-05-04
CA2599502C (en) 2013-05-14
SI1858491T1 (sl) 2011-09-30
US20060210632A1 (en) 2006-09-21
HK1109730A1 (en) 2008-06-20
US20080226717A1 (en) 2008-09-18
BRPI0608505B1 (pt) 2021-05-04
WO2006097361A1 (en) 2006-09-21
ZA200707900B (en) 2009-01-28
KR20070114756A (ko) 2007-12-04
FR2883179B1 (fr) 2009-04-17
NZ561154A (en) 2010-12-24
CN101141951B (zh) 2011-02-09
CA2599502A1 (en) 2006-09-21
JP5138577B2 (ja) 2013-02-06
BRPI0608505A2 (pt) 2010-01-05
PL1858491T3 (pl) 2012-03-30
IL185626A (en) 2014-09-30
US8709479B2 (en) 2014-04-29
BRPI0608505B8 (pt) 2021-05-25
FR2883179A1 (fr) 2006-09-22
MX2007011440A (es) 2007-11-14
AU2006224690A1 (en) 2006-09-21
ES2365984T3 (es) 2011-10-14
JP2008533084A (ja) 2008-08-21
RU2403043C2 (ru) 2010-11-10
AU2006224690B2 (en) 2011-09-29
DK1858491T3 (da) 2011-08-22
CN101141951A (zh) 2008-03-12
IL185626A0 (en) 2008-01-06
DE602006021713D1 (de) 2011-06-16
NO20075345L (no) 2007-12-17
NO338771B1 (no) 2016-10-17
ATE507824T1 (de) 2011-05-15
EP1858491A1 (en) 2007-11-28
UA88509C2 (ru) 2009-10-26

Similar Documents

Publication Publication Date Title
CY1111729T1 (el) Υπογλωσσιο επικαλυμμενο δισκιο
DK1879623T3 (da) Genterapi til rygmarvssygdomme
UY3723Q (es) Aerosol
EA200802008A1 (ru) Фармацевтические композиции
DE602005020968D1 (de) n dafür
DE602005014129D1 (de) Rohrleitung
DK1957073T3 (da) Lægemiddel
BRPI0719398A2 (pt) Composição farmacêutica.
ME01459B (me) Postupak za doziranje medikamenata
BRPI0618332A2 (pt) embalagem
DE602006018435D1 (de) Surround-System
ITTO20050241A1 (it) Impianto dentario intraosseo.
DE602005015495D1 (de) Beschichteter kaugummi
NO20043033L (no) Rorplassering
ITBO20050375A1 (it) Riunito dentale
NO20091386L (no) Fenyloksyanilinderivater
FI20041538A (fi) Goniometri
ITTO20060147A1 (it) Alzavalvola e procedimento per la sua produzione.
DK1720557T3 (da) Hurtig-opløselig, smagsmaskeret tablet
FI20061160A0 (fi) Puurakenteinen pakkauskehä
DK1934388T3 (da) Fremgangsmåde til lægemiddeludvikling
FI20041361A (fi) Pakkausmateriaalit
ITBO20060023U1 (it) Orecchino pendente.
NO20045094L (no) Emballasje
ES1059640Y (es) Mantel con puntilla